Trials
Search / Trial NCT05661370

App Teaches Doctors to Diagnose Skin Cancer

Launched by HERLEV HOSPITAL · Dec 13, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Completed

Keywords

Digital Learning E Learning Melanoma Carcinoma Dermoscopy Dermloop

ClinConnect Summary

Participants were given a questionnaire and an initial Skin Cancer Multiple Choice-Questionnaire (MCQ) to test their diagnostic skills regardining skin and mole cancer and the most common differential diagnoses.

Participants in the Intervention group was then given access to an educational mobile application (App) for 8 days and asked to diagnose 500 patient cases. The participants did so at their own leisure and time.

After 8 days they were asked to abstain from using the App for another 8 days (wash out period) and were then given a Final Skin Cancer Multiple Choice-Questionnaire (MCQ)....

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Primary Care Physician who works in General Practice
  • Exclusion Criteria:
  • • -

About Herlev Hospital

Herlev Hospital, a leading healthcare institution located in Denmark, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a key player in the Danish healthcare system, Herlev Hospital combines cutting-edge facilities with a multidisciplinary approach to research, fostering collaborations among healthcare professionals and researchers. The hospital focuses on a wide range of medical fields, aiming to enhance treatment efficacy and patient care through rigorous scientific inquiry and ethical standards. With a commitment to excellence, Herlev Hospital plays a pivotal role in translating clinical research findings into practical applications that benefit patients and the broader community.

Locations

Copenhagen, Danmark, Denmark

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials